.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
AstraZeneca
Citi
McKinsey
Argus Health
Johnson and Johnson
UBS
Moodys
Julphar
Boehringer Ingelheim

Generated: June 26, 2017

DrugPatentWatch Database Preview

VINORELBINE TARTRATE Drug Profile

« Back to Dashboard

Which patents cover Vinorelbine Tartrate, and when can generic versions of Vinorelbine Tartrate launch?

Vinorelbine Tartrate is a drug marketed by Jiangsu Hansoh Pharm, Ebewe Pharma, Actavis Totowa, Dr Reddys Labs Ltd, Hospira, Teva Pharms Usa, Mylan Labs Ltd, Fresenius Kabi Usa, and West-ward Pharms Int. and is included in ten NDAs.

The generic ingredient in VINORELBINE TARTRATE is vinorelbine tartrate. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the vinorelbine tartrate profile page.

Summary for Tradename: VINORELBINE TARTRATE

Patents:0
Applicants:9
NDAs:10
Suppliers / Packagers: see list6
Bulk Api Vendors: see list47
Clinical Trials: see list448
Patent Applications: see list5,424
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VINORELBINE TARTRATE at DailyMed

Pharmacology for Tradename: VINORELBINE TARTRATE

Ingredient-typeVinca Alkaloids
Drug ClassVinca Alkaloid
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jiangsu Hansoh Pharm
VINORELBINE TARTRATE
vinorelbine tartrate
INJECTABLE;INJECTION091106-001Sep 26, 2012APRXNoNo► Subscribe► Subscribe
Mylan Labs Ltd
VINORELBINE TARTRATE
vinorelbine tartrate
INJECTABLE;INJECTION200148-001Aug 31, 2012APRXNoNo► Subscribe► Subscribe
Dr Reddys Labs Ltd
VINORELBINE TARTRATE
vinorelbine tartrate
INJECTABLE;INJECTION202017-001Sep 12, 2013APRXNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
VINORELBINE TARTRATE
vinorelbine tartrate
INJECTABLE;INJECTION076849-001Apr 18, 2005APRXNoNo► Subscribe► Subscribe
Ebewe Pharma
VINORELBINE TARTRATE
vinorelbine tartrate
INJECTABLE;INJECTION078408-001Feb 13, 2008DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Healthtrust
US Department of Justice
McKesson
Covington
Julphar
Harvard Business School
Chubb
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot